Brief: Sensorion Allowed To Start SENS-401 PoC Clinical Trial In France

Sensorion SA

07/06/2022 06:34

June 7 (Reuters) - SENSORION SA  ALSEN.PA :
    * SENSORION ANNOUNCES APPROVAL IN FRANCE TO INITIATE PROOF
OF
CONCEPT CLINICAL TRIAL OF SENS-401 FOR RESIDUAL HEARING
PRESERVATION DURING COCHLEAR IMPLANTATION
    * AS PREVIOUSLY ANNOUNCED, FIRST PATIENT ENROLMENT IS
ANTICIPATED
BY MID-2022
    * PATIENTS WILL RECEIVE SENS-401 FOR 49 DAYS

Source text for Eikon:  ID:nBw9BmF96a 
Further company coverage:  ALSEN.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))